MedTrace Logo

Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction

NCT01997294 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2016-10-11

No results posted yet for this study

Summary

Statins have been approved to benefit patients underwent percutaneous coronary intervention (PCI). The current study is designed to evaluate the effectiveness and safety of Sequential Therapy of Atorvastatin in patients with ST-elevated myocardial infarction and receive PCI treatment.

Conditions

  • Acute Myocardial Infarction

Interventions

DRUG

Sequential therapy of atorvastatin

80mg atorvastatin before PPCI and 40mg/d for 7 days after PPCI

Sponsors & Collaborators

  • Zhang Qi, MD

    lead OTHER

Principal Investigators

  • Weifeng Shen, MD. PhD. · Institute of Cardiovascular Diseases, School of Medicine, Shanghai Jiao Tong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01997294 on ClinicalTrials.gov